Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Apr 10, 2022
Episode | Date |
---|---|
Blood based and Stool DNA colon cancer screening - Two NEJM papers
|
Mar 27, 2024 |
Keynote 564 - a flawed study
|
Feb 01, 2024 |
CONTACT-01 Cabo/ Atezo in Prostate Cancer - An Unethical trial
|
Jan 27, 2024 |
CAR T causes MDS??? Manni, Goodman, Raj, Prasad
|
Dec 28, 2023 |
Timothee and Prasad talk 2023 cancer trials
|
Dec 24, 2023 |
Aaron Goodman Prasad ASH UPDATES
|
Dec 20, 2023 |
Mandrola and Prasad
|
Dec 17, 2023 |
COVID19 Policy: What the US Got Wrong
|
Nov 26, 2023 |
Lecture 1 of 4 Curacao - How to Keep Up with Literature
|
Nov 24, 2023 |
Advice Pre-Med Students | Lecture at UC Berkeley
|
Nov 11, 2023 |
Radiation oncology in GI malignancy - Nina Sanford and Bill Hall
|
Oct 31, 2023 |
Hawai Keynote - Coffee and colon cancer & Censoring & More
|
Oct 23, 2023 |
Ethics: How IRBs Can Do Better | My Denmark Lectures (Sept 2023) 3 Of 3
|
Oct 19, 2023 |
Prasad's lecture gets cancelled/ Cifu Gets COVID a SM crossover
|
Oct 16, 2023 |
The State Of Immunotherapy In Oncology | My Denmark Lectures (Sept 2023) 2 Of 3
|
Oct 09, 2023 |
Do We Have Good Evidence For New Drugs? My Denmark Lectures (Sept 2023) 1 Of 3
|
Oct 04, 2023 |
Great And Crazy Things We Do In Medicine
|
Sep 20, 2023 |
Fixing Cancer Medicine w/ Timothee Olivier
|
Sep 12, 2023 |
Coumadin, ECMO, RCTs and more
|
Sep 11, 2023 |
Prasad and Mandrola discuss recent journal articles/ Republicans/ Stenting
|
Aug 23, 2023 |
Placebo/ Journal Errors/ Cancer Screening w/ Mandrola - SM crossover
|
Jul 10, 2023 |
Testosterone/ Should Scientists Debate/ Mike Joyner
|
Jun 28, 2023 |
Post Protocol Therapy - QOL - Adjuvant - Olivier Joins VP
|
Jun 10, 2023 |
ADAURA OS RESULTS - THE TRIAL WAS UNETHICAL
|
Jun 08, 2023 |
OBS studies vs RCTs - Trial Emulation - RCT Duplicate - We debate recent JAMA Paper
|
May 17, 2023 |
Myeloma Roundtable - Manni M. Raj C. VP discuss controversies
|
May 13, 2023 |
Mammographic Screening : A complete review of the evidence
|
May 11, 2023 |
The Crushing, Cruel Cost of Cancer Drugs - My Lecture
|
Apr 29, 2023 |
Sensible Med Crossover - Cifu/ Mandrola/ Prasad & Wallensky
|
Apr 24, 2023 |
Cochrane Mask Debates - Jefferson/ Heneghan/ Prasad
|
Apr 15, 2023 |
Zeb Jamrozik - Vaccine errors/ Sweden/ Equipoise & Science itself
|
Apr 12, 2023 |
Harvard-MIT Center for Reg. Science Lecture (4-4-23) - Dubious FDA drug Approvals
|
Apr 05, 2023 |
5.47 - Real World Evidence - Keynote Lecture in Denmark
|
Mar 26, 2023 |
5.46 - What is Science: reflections on the field
|
Mar 10, 2023 |
5.45 - Bar Karmma - Karmma 3 | Idacel vs 'standard care
|
Mar 07, 2023 |
More basics on randomized controlled trials - Part 2
|
Mar 02, 2023 |
RCT 101 And Papa Heme
|
Feb 28, 2023 |
Tom Newman And VP Discuss Public Health
|
Feb 22, 2023 |
5.41 - Michael Putman MCW debates me on recent policy Qs
|
Feb 16, 2023 |
Sensible Med Superbowl Plenary Session Crossover
|
Feb 13, 2023 |
5.39 - Sotorasib and Codebreak 200
|
Feb 10, 2023 |
Myeloma Twitter Just Makes Things Up - Lessons for All Oncologists & Expertise
|
Jan 22, 2023 |
5.37 - Keynote Lecture on Physician Burnout
|
Jan 15, 2023 |
5.36 - ASH UPDATE #4 - GEM CESAR
|
Dec 30, 2022 |
5.35 - ASH Update #3 - the Ascent Trial
|
Dec 29, 2022 |
5.34 - ASH Update #2 - ALPINE - Zanibrutinib vs Ibrutinib - Deconstructed
|
Dec 24, 2022 |
5.33 USC Grand Rounds Hematology
|
Dec 23, 2022 |
5.32 - ASH Update #1 - Talquetamab NEJM
|
Dec 11, 2022 |
5.31 - MUST LISTEN Grand Rounds - COVID19 Updates
|
Dec 08, 2022 |
5.30 Rajkumar vs Goodman; Long COVID vs Long URI
|
Dec 03, 2022 |
5.29 Smart Start is a useless Lymphoma study
|
Nov 27, 2022 |
5.28 - Pandemic Amnesty or Accountability with Paul Fenyves
|
Nov 12, 2022 |
5.27 - Multiple Myeloma - Do Our Trials Help Patients?
|
Nov 08, 2022 |
5.26 - Hawaii Oncology Association Keynote Lecture
|
Nov 06, 2022 |
5.25 - Neurosurgery Grand Rounds by Vinay Prasad
|
Nov 03, 2022 |
5.24 Vlad Kogan is back to discuss Kids Test Scores
|
Nov 01, 2022 |
5.24 - Gerald Hsu MD PhD UCSF Heme Onc Program Director
|
Oct 28, 2022 |
5.23 - Subclinical Myocarditis
|
Oct 19, 2022 |
5.23 - ID Ethicist joins me for a 6th discussion of COVID19 policy
|
Oct 18, 2022 |
5.22 NordICC trial interview with PI Michael Bretthauer - Offer but don't Nudge
|
Oct 15, 2022 |
5.21 Science Mag Editor Condemns Ladapo But Silent About Jha
|
Oct 14, 2022 |
5.20 The Great Colonoscopy Debate
|
Oct 11, 2022 |
5.19 - NEJM's first ever RCT of Colonoscopy-- Explained
|
Oct 09, 2022 |
5.18 Lecture to Heme Onc Fellows - POLO; Javelin 100 bladder
|
Oct 08, 2022 |
5.17 - The State Of Precision Oncology
|
Oct 07, 2022 |
5.16 - Aaron Goodman UCSD
|
Sep 29, 2022 |
5.15 - How To Apply For And Get Your Perfect First Job
|
Sep 21, 2022 |
Unspoken Rules of Oncology - Malignant BC Part 6
|
Sep 18, 2022 |
Malignant Book Club - Episode 7 - famous trials
|
Sep 09, 2022 |
5.12 - Academics Vs Industry - A.Goodman S.Loghavi D.Steensma V.P.
|
Sep 03, 2022 |
5.11 - Malignant Book Club - Part 5
|
Aug 26, 2022 |
5.10 - Adam Cifu on clinical excellence
|
Aug 24, 2022 |
5.09 - Malignant Book Club Part 4
|
Aug 22, 2022 |
5.08 - LaceWing RCT Phase 3 Blood - Spin Cycle
|
Aug 18, 2022 |
5.07 - Plenary Session Alps Edition
|
Aug 10, 2022 |
5.06 - POLO trial now has OS results - OMG
|
Jul 21, 2022 |
5.05 - Citations, Metrics, Rankings in Oncology & Medicine
|
Jul 18, 2022 |
5.04 - Echelon 1 reports OS benefit - But does it add up?
|
Jul 14, 2022 |
5.03 - VPs Grand Rounds Lecture - Evidence Based Medicine - Will it Survive?
|
Jul 13, 2022 |
5.02 - Listener Questions - Cancer & Evidence Philosophy - What this Pod Offers
|
Jul 11, 2022 |
5.01 - How To Read Randomized Trials In Cancer
|
Jul 07, 2022 |
Lies and Exaggerations about Kids Vaccines < 5 years Old is Bad Public Health
|
Jun 22, 2022 |
Enact Trial - Enza vs Active Surveillance in Localized Prostate Cancer
|
Jun 20, 2022 |
Kids Vaccine For Under 5 years Old
|
Jun 18, 2022 |
H. Jack West; Lung Cancer; Podcasting; TeleHealth: PACIFIC; ADAURA;CM816: KN189
|
Jun 18, 2022 |
QuANTUM - Quizartinib Front Line - Ethics of Global Trials
|
Jun 15, 2022 |
4.67 Teclistimab for R/R Multiple Myeloma
|
Jun 09, 2022 |
4.66 PD1 Ab for MSI H Stage II/ III Rectal Cancer; A 100% CR rate??
|
Jun 08, 2022 |
4.65 DESTINY BREAST 04 - A complex trial to deconstruct
|
Jun 07, 2022 |
4.64 - DETERMINATION - Should we still use transplant Myeloma?
|
Jun 06, 2022 |
4.63 - ASCO22 - DYNAMIC - Can CT DNA Allow us to Give Less Chemo in Stage II Colon Cancer
|
Jun 05, 2022 |
4.62 - SHINE - Ibrutinib BR vs BR; Limitations to the trial
|
Jun 04, 2022 |
4.61 - How CDC's Vaccine Safety Missed Cases Of Myocarditis
|
May 27, 2022 |
4.60 - NEW JCO paper - AML, EFS, CR, CRi, and Surrogate validation - FDA & Methods
|
May 21, 2022 |
4.59 - How to be a better reader of case control studies
|
May 17, 2022 |
4.58 - Myeloma is a broken field - New BLOOD Paper!
|
May 14, 2022 |
4.57 - COVID19 and the Failures of Public Health w/ Leslie Bienen
|
May 06, 2022 |
4.56 - Fifth Installment of the brilliant Zeb Jamrozik
|
May 04, 2022 |
4.55 - Compilation Of Recent Covid Monologues
|
May 01, 2022 |
4.54 - Eric Collisson Professor, GI Oncologist, Physician Scientist
|
Apr 30, 2022 |
4.53 John Ioannidis lectures the VKPrasad Lab about COVID19
|
Apr 27, 2022 |
4.52 Vinay Prasad Gives a Lecture on COVID19 to a General Audience
|
Apr 24, 2022 |
4.51 - Vinay Prasad is Interviewed by Kristina Jenei About Academic Medicine
|
Apr 22, 2022 |
4.50 - Ivosidenib & Aza vs Aza, the AGILE, 6 huge problems; Journal club
|
Apr 21, 2022 |
4.49 - Malignant Book Club Part 3 Audio
|
Apr 15, 2022 |
4.48 - The Truth About RCTs In Cancer Medicine
|
Apr 07, 2022 |
4.47 Malignant Book Club w/ Dr. Olivier Part 2 of 9
|
Mar 22, 2022 |
4.46 - Cancer Monologue and Lecture #5 from VP's Class on How to Appraise Medical Literature
|
Mar 16, 2022 |
4.45 - Malignant Book Club w/ Dr. Olivier Part 1 of 9
|
Mar 12, 2022 |
4.44 - Cost Of Cancer Drugs - Basics In Cancer Drug Policy
|
Mar 04, 2022 |
4.43 - VKPrasad Lab Update Part 2 With Timothee Olivier
|
Mar 01, 2022 |
4.42 - Timothee Olivier, Geneva in the first Installment of VKPrasad Lab updates
|
Feb 24, 2022 |
4.41 The Mask Debacle with Jacob Hale Russell
|
Feb 19, 2022 |
4.40 H Gilbert Welch - Melanoma Screening; Blood Based Cancer testing; Lung CA screening
|
Jan 28, 2022 |
4.39 Dr Zeb Jamrozik, ID ethicist, practicing doctor, great thinker
|
Jan 27, 2022 |
4.38 COVID-19: Boosters for Adults and Teens, Paul Offitt, Testing, Myocarditis, Campus Restrictions
|
Jan 21, 2022 |
4.37 MEMOIR & The Emperor Has No Clothes (a Critique of Cancer Care) with Dr. Christopher Booth
|
Jan 06, 2022 |
4.36 Where Are We Now with COVID-19? with Dr. John Ioannidis
|
Jan 04, 2022 |
4.35 Omicron, Travel Bans, Masks, Vaccine Mandates with Dr. Zeb Jamrozik
|
Dec 31, 2021 |
4.34 ASH Lymphoma Updates: POLARIX, ZUMA 7, BELINDA w/ Papa Heme and DRG
|
Dec 24, 2021 |
4.33 Melanoma: Tebentafusp, Stage Migration, Adjuvant Therapy, Training with Dr. Adil Daud
|
Dec 22, 2021 |
4.32 Oral Azacitidine for AML and Nelarabine for T-ALL with Dr. Bernard Marini
|
Dec 03, 2021 |
4.31 Neoadjuvant Radiation Therapy in Pancreatic Adenocarcinoma with Dr. William Hall
|
Nov 24, 2021 |
4.30 COVID in Children and the US FDA Vaccine Advisory Committee with Dr. Cody Meissner
|
Nov 22, 2021 |
4.29 Scientific and Ethical Failures of COVID-19 with Dr. Zeb Jamrozik
|
Nov 11, 2021 |
4.28 Calling Out Unethical Clinical Trials, Melflufen, and Academic Oncology with Dr. Aaron Goodman
|
Nov 06, 2021 |
4.27 Economics and Medicine with the Host of Freakonomics, M.D., Dr. Anupam Bapu Jena
|
Oct 29, 2021 |
4.26 Recent Kidney Cancer Trials, Unethical Cancer Clinical Trial, & CASSIOPEIA
|
Oct 28, 2021 |
4.25 A Critique of COVID-19 Health Policy with Infectious Disease Ethicist Dr. Zeb Jamrozik
|
Oct 20, 2021 |
4.24 COVID-19: Moderna booster, Myocarditis, Progressivism, Social Media, Masks, Tests, J&J booster
|
Oct 16, 2021 |
4.23 Access to Cancer Medicines, Standard of Care in Oncology, and the Oncology Value Paradigm
|
Oct 15, 2021 |
4.22 Honoring Dr. Elilhu Estey and His Decades-Long Oncology Career
|
Oct 12, 2021 |
4.21 Cognitive Errors in Medical Decision-Making with Dr. Daniel Morgan & COVID-19 Policy
|
Sep 22, 2021 |
4.20 Vaccinating Kids and College Students, Boosters, Outdoor Masking, Bangladesh RCT, & more!
|
Sep 14, 2021 |
4.19 Censoring: Not on Facebook, but in Kaplan-Meier Curves
|
Sep 08, 2021 |
4.18 Dementia Interventions, Skills for Epidemiologists, & Aducanumab with Dr. Maria Glymour
|
Sep 01, 2021 |
4.17 RCTs for Cancer Drug Approval with Dr. Saroj Niraula & Myeloma Studies with Dr. Manni Mohyuddin
|
Aug 27, 2021 |
4.16 Treating Lymphoma, Histiocytic Disorders, Learning by Teaching, & More! with Dr. Bita Fakhri
|
Aug 21, 2021 |
4.15 #AllCOVID-19: the Tough Questions About Policies Concerning the Delta Variant of COVID-19
|
Aug 19, 2021 |
4.14 Evolution of GI Cancer Therapy, Editing JCO, Advice for Clinical Trialists with Dr. Alan Venook
|
Aug 11, 2021 |
4.13 Lessons from Publishing 300 Peer-Reviewed Papers & What Telemedicine Will Do to Cancer Care
|
Aug 06, 2021 |
4.12 Real-World Survival Outcomes for Pertuzumab and T-DM1 with Dr. Josee-Lyne Ethier
|
Aug 03, 2021 |
4.11 CheckMate 274, PARADIGM-HF/Ernesto, POLO, & an AI Approach to Reducing Knee Pain
|
Jul 31, 2021 |
4.10 A Deep Dive into CheckMate 649 with Dr. Jeffrey Bien
|
Jul 28, 2021 |
4.09 Problems with the VISION Trial & Stool Transplant Plus Nivo for Metastatic Melanoma
|
Jul 23, 2021 |
4.08 Implications for the Fate of Accelerated Approval from the ODAC Votes of April 2021
|
Jul 16, 2021 |
4.07 Questions from a Medical Student with Emma Greenstreet and Dr. Vinay Prasad
|
Jul 09, 2021 |
4.06 CAR-T, Oncology RCTs, Social Media, Myeloma, and Career Decisions with Dr. Rahul Banerjee
|
Jul 08, 2021 |
4.05 Exodus from Academia and the Regretful FDA Approval of Aducanumab with Dr. Ameet Sarpatwari
|
Jul 07, 2021 |
4.04 Treatment Algorithm for Follicular Lymphoma & Assessing RCTs
|
Jun 26, 2021 |
4.03 Multiple Myeloma, Productivity Metrics, and Field Changes in Oncology with Dr. Nina Shah
|
Jun 18, 2021 |
4.02 The History of Breast Cancer Research and Treatment with Dr. George Sledge
|
Jun 15, 2021 |
4.01 Highlights from the 2021 ASCO Annual Meeting
|
Jun 11, 2021 |
3.90 Redesigning Health Care, Overuse, Burnout, and COVID-19 Groupthink with Dr. Marty Makary
|
Jun 04, 2021 |
3.89 How to Think About COVID-19 Policy with Rare Events and Declining Probabilities
|
Jun 03, 2021 |
3.88 Behind the Scenes for the One-Year Anniversary of Malignant with Dr. Vinay Prasad
|
Jun 02, 2021 |
3.87 Round Table on Multiple Myeloma Initial Therapy, High Risk, and Maintenance
|
May 31, 2021 |
3.86 Lenvatinib plus Pembrolizumab or Everolimus for Advanced RCC with Dr. Karine Tawagi
|
May 28, 2021 |
3.85 Med-Psych, Palliative Care, and Respect for Autonomy and Dignity with Dr. Joshua Briscoe
|
May 27, 2021 |
3.84 DLBCL, Bad Cancer Drugs and Bad Twitter Users with Dr. Aaron Goodman
|
May 26, 2021 |
3.83 MetaResearch, Reproducibility, Expertise, & Early Career Researchers with Dr. Ioana Cristea
|
May 25, 2021 |
3.82 Classical Hematology Chat on CVT and VITT with Drs. Sven Olson and Joseph Shatzel
|
May 24, 2021 |
3.81 Impact of COVID-19 on Sociology, Politics, and Democracy with Genève Campbell
|
May 21, 2021 |
3.80 ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) with Drs. Bishal Gyawali and Nathan Cherny
|
May 20, 2021 |
3.79 Sweden's Stance on COVID-19, Hydroxychloroquine, Schools, & Mask Data with Dr. Cathrine Axfors
|
May 19, 2021 |
3.78 Astronomy, Being a Scientist, and the Culture of the Academy with Dr. Avi Loeb
|
May 18, 2021 |
3.77 Reporting of Race in US FDA Registration Trials with Dr. Mark Lythgoe
|
May 17, 2021 |
3.76 COVID-19 Transmission in Schools with Dr. Christopher Whaley and Dr. Neeraj Sood
|
May 14, 2021 |
3.75 All Things COVID-19 with Infectious Disease Professor Dr. Paul Edward Sax
|
May 14, 2021 |
3.74 Artificial Intelligence in Dermatology with Dr. Roxana Daneshjou
|
May 13, 2021 |
3.73 CheckMate 577: Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer
|
May 12, 2021 |
3.72 Industry Payments to US Physicians for Cancer Therapeutics with Dr. Daniel Meyers
|
May 11, 2021 |
3.71 How Research Influences Policy with Dr. Kirsten Bibbins-Domingo
|
May 05, 2021 |
3.70 The Motivation We Need to Reach the End of the COVID-19 Pandemic with Dr. Monica Gandhi
|
Apr 30, 2021 |
3.69 Reporting of Postprotocol Therapies in Multiple Myeloma with Dr. Ghulam Rehman Mohyuddin
|
Apr 29, 2021 |
3.68 A Career in Academic Medicine & Challenges of 2021 with Former Harvard Dean, Dr. Jeffrey Flier
|
Apr 29, 2021 |
3.67 Thoughts on PhD Programs and Idecabtagene Vicleucel with Dr. David Russler-Germain
|
Apr 23, 2021 |
3.66 COVID-19 Policies and Progressing Past Disagreement with Dr. Martin Kulldorff
|
Apr 16, 2021 |
3.65 Banning Books, Social Media, & Medical Education with Dr. Adam Cifu
|
Apr 14, 2021 |
3.64 A Legal and Philosophical View on COVID-19 with Samantha Godwin
|
Apr 12, 2021 |
3.63 The Medical Scientist Training Program with Dr. David Russler-Germain
|
Apr 08, 2021 |
3.62 COVID-19 Transmission, Vaccines, & Olaparib with Dr. Tom Beer
|
Apr 08, 2021 |
3.61 The Neuroscience and Psychology of Recreational Drug Use in Adults with Dr. Carl Hart
|
Apr 06, 2021 |
3.60 Drugs for Acute Lymphoblastic Leukemia with Dr. Bernard Marini
|
Mar 31, 2021 |
3.59 Genetic Alterations Linked to SARS-CoV-2 Acquisition and Bad Outcomes with Dr. Nathan Pearson
|
Mar 30, 2021 |
3.58 Expertise and Disinformation with Jacob Hale Russell
|
Mar 26, 2021 |
3.57 Career Paths and Evolution of the Oncology Randomized Clinical Trial with Dr. Christopher Booth
|
Mar 26, 2021 |
3.56 Quality of Control Groups in RCTs of Multiple Myeloma with Dr. Ghulam Rehman Mohyuddin
|
Mar 25, 2021 |
3.55 Equity in Vaccine Distribution, Cancel Culture, and Zero COVID-19 with Dr. Matthew Smith
|
Mar 24, 2021 |
3.54 The Passing of Dr. José Baselga
|
Mar 23, 2021 |
3.53 Updates on COVID-19 and Looking Back Over the Last Year with Dr. Aaron Richterman
|
Mar 19, 2021 |
3.52 Medicine, Leadership, SARS-CoV-2, and Social Media with Dr. Bob Wachter
|
Mar 14, 2021 |
3.51 COVID-19 Modeling with Youyang Gu
|
Mar 12, 2021 |
3.50 Evildoer Marty Makary [SHORT]
|
Mar 11, 2021 |
3.49 The Role of Government in Public Health and in COVID-19 Policy with Dr. Robert Freudenthal
|
Mar 10, 2021 |
3.48 The Predictive Value of High Tumor Mutational Burden with Dr. Luc Morris
|
Mar 06, 2021 |
3.47 COVID-19 Vaccine Results, Messaging on a Patient Level, & Schools with Dr. Monica Gandhi
|
Mar 03, 2021 |
3.46 COVID-19 Risk, Cases, and Transmission in K-12 Schools with Dr. Tracy Høeg
|
Feb 27, 2021 |
3.45 USMLE Steps, Residency Match, & M.D. vs D.O. with Dr. Bryan Carmody
|
Feb 24, 2021 |
3.44 The Role of Philosophy, COVID-19 Policy, and COVID-19 Exceptionalism with Dr. Alex John London
|
Feb 17, 2021 |
3.43 Reviewing the Beat AML Master Trial
|
Feb 15, 2021 |
3.42 Overdiagnosis and Cutaneous Melanoma Diagnoses with Dr. Adewole Adamson and Dr. Benjamin Mazer
|
Feb 10, 2021 |
3.41 Building a Meta-Research Career and Constructing COVID-19 Health Policy with Dr. John Ioannidis
|
Feb 07, 2021 |
3.40 COVID-19 Vaccines, Origin of SARS-CoV-2, and Pandemic Mitigation with Prof Francois Balloux
|
Feb 05, 2021 |
3.39 Public Health Messaging on COVID-19 with Drs. Julia Marcus and Stefan Baral
|
Feb 04, 2021 |
3.38 Oncology During COVID-19 & RCTs from Low- vs High-Income Countries with Dr. Christopher Booth
|
Jan 29, 2021 |
3.37 Skepticism, COVID-19, and Debating Science in the Era of Trade-Offs with Jacob Hale Russell
|
Jan 27, 2021 |
3.36 Sustainable Ex-Vivo Seafood with Dr. Arye Elfenbein
|
Jan 22, 2021 |
3.35 The Secrets of Vermont in Taming the COVID-19 Pandemic with Anne Sosin
|
Jan 20, 2021 |
3.34 COVID-19 From a Philosopher's Point of View with Dr. Matthew Smith
|
Jan 15, 2021 |
3.33 Hematologic Malignancies and Transplantation with Dr. Aaron Goodman
|
Jan 12, 2021 |
3.32 Publishing Original Thought in Medical Journals with Dr. Stephen Bradley
|
Jan 08, 2021 |
3.31 Random Thoughts on Visiting Hospital Patients During COVID-19 and Norman Wang's Lawsuit
|
Jan 06, 2021 |
3.30 Benefit and Risk of SpaceOAR with Dr. William Hall
|
Jan 05, 2021 |
3.29 Censorship in Medicine with Jonathan Darrow
|
Dec 31, 2020 |
3.28 Exploring the History of Medicine with Dr. Adam Rodman, host of Bedside Rounds
|
Dec 21, 2020 |
3.27 All Recent Acute Myeloid Leukemia Drugs with Dr. Bernard Marini
|
Dec 16, 2020 |
3.26 The Importance of Debate and Dialogue with Dr. Saurabh Jha
|
Dec 15, 2020 |
3.25 Public Health Policy on the Risk of COVID-19 in Children with Dr. Alasdair Munro
|
Dec 12, 2020 |
3.24 KEYNOTE-177 & Mathematic Models for Fighting COVID-19 with Dr. Wesley Pegden
|
Dec 04, 2020 |
3.23 Capturing Your Audience with Dr. Zubin "ZDoggMD" Damania & JAVELIN 100 with Dr. Karine Tawagi
|
Nov 26, 2020 |
3.22 New Podcast, Opening Schools with Dr. Vladimir Kogan, Virtual Learning with Dr. Carycruz Bueno
|
Nov 21, 2020 |
3.21 Affirmative Action with Leah Litman, Cost Implications with Dr. DeMartino, & Dr. John Mandrola
|
Nov 13, 2020 |
3.20 Public Health Messaging, COVID-19 in the U.S. Northeast, Journal Club with a Fellow
|
Nov 07, 2020 |
3.19 COVID-19 and the AIDS Pandemics with Dr. Monica Gandhi & Classical Hematology Chat
|
Oct 30, 2020 |
3.18 Social Media and News with Dr. Benjamin Mazer & Caplacizumab for TTP with Dr. Tem Bendapudi
|
Oct 23, 2020 |
3.17 COVID-19 and Schools in Norway with Dr. Atle Fretheim & Cancer Biology with Dr. Anthony Letai
|
Oct 16, 2020 |
3.16 Non-Drug Interventions with Dr. Margaret McCartney & Cancer Biology with Dr. Jason Sheltzer
|
Oct 09, 2020 |
3.15 COVID-19 in Children with Dr. Alasdair Munro & Pandemic Public Health with Dr. Stefan Baral
|
Oct 06, 2020 |
3.14 COVID-19 with Dr. John Ioannidis & Trial Eligibility with Dr. Mary-Elizabeth Percival
|
Oct 03, 2020 |
3.13 COVID-19 and Schools, COVID-19 and Scott Atlas, and COVID-19 Policy
|
Sep 25, 2020 |
3.12 TMPRSS2, Cancer Imaging with Drs. Becker and Woo, Clinical Epidemiology with Dr. Thomas Newman
|
Sep 19, 2020 |
3.11 Experts, Lockdown, Affirmative Action, & COVID-19 and Hearts with Professor Darrel Francis
|
Sep 12, 2020 |
3.10 Colon Cancer Screening, Vascepa Patent with Jonathan Darrow, PREVENTT with Dr. Toby Richards
|
Sep 05, 2020 |
3.09 COVID-19 Risk, Financial Toxicity, & HALT-IT for Journal Club with Fellow Dr. Justine Ryu
|
Aug 29, 2020 |
3.08 Racial Concordance in Birthing Mortality & HERO for Journal Club with Fellow Dr. Michael Burns
|
Aug 22, 2020 |
3.07 Lung Cancer Omics and Mortality, PPIs and COVID-19, & RECIST with Dr. Elizabeth Eisenhauer
|
Aug 15, 2020 |
3.06 COVID-19 Vaccine Access, ADAURA, QOTW, & Journal Club with Fellow Dr. Karine Tawagi
|
Aug 07, 2020 |
3.05 LIVE! A Midsummer Night's Stream
|
Jul 30, 2020 |
3.04 Listener Questions & MedTwitter and Risk-Benefit Profile of Ramucirumab with Dr. Bishal Gyawali
|
Jul 24, 2020 |
3.03 The National Lung Matrix Trial & the Major Flaw of the SPRINT Trial with Dr. Mark Friedberg
|
Jul 18, 2020 |
3.02 BONUS! National Clinician Scholars Program with Dr. Hilary Seligman
|
Jul 13, 2020 |
3.01 Risk of COVID-19 Among Users of PPIs, Time to Treatment Initiation, & Dr. Lynora Saxinger
|
Jul 11, 2020 |
2.60 BONUS! Cancer Meta-Research 101: The Lay of the Land of Cancer Research
|
Jul 07, 2020 |
2.59 The Best Doctor, Selinexor, & Annotation Services for NGS with Drs. Katsoulakis and Kelley
|
Jul 03, 2020 |
2.58 RECOVERY & Twitter, Academic Debate, and Transitioning Your Career with Dr. Andrae Vandross
|
Jun 27, 2020 |
2.57 RECOVERY, Clinical Trials in the US, EFS, Writing, Dr. Raj Chetty, & Dr. Ian Tannock
|
Jun 19, 2020 |
2.56 HER2CLIMB & Misinformation and Disinformation with Dr. Cailin O'Connor
|
Jun 12, 2020 |
2.55 Hydroxychloroquine for COVID-19, ASCO, QOTW, Private Equity in Medicine with Dr. Jane Zhu
|
Jun 05, 2020 |
2.54 Classical Hematology Chat on Thrombosis in COVID-19 & Drugs for COVID-19 with Dr. Walid Gellad
|
May 31, 2020 |
2.53 Why Agreeing 65% with Someone is Important & COVID-19 Health Policy with Dr. Daniel Morgan
|
May 23, 2020 |
2.52 Malignant Audiobook, PROfound trial, & Literature and Medicine with Dr. Adam Cifu
|
May 16, 2020 |
2.51 BONUS! Clinical Trials Part 3
|
May 13, 2020 |
2.50 Neil Ferguson, Ending Lockdown, & Updates on COVID-19 Management with Dr. Benjamin Singer
|
May 07, 2020 |
2.49 COVID-19 Contrarians, Remdesivir, & Book Club on "Malignant" with OHSU HemOnc Fellows
|
May 02, 2020 |
2.48 BONUS! Introduction to Malignant: How Bad Policy and Bad Evidence Harm People with Cancer
|
Apr 25, 2020 |
2.47 Remdesivir, Cloth Masks, & Incentives for COVID-19 Drug Development with Dr. Ameet Sarpatwari
|
Apr 16, 2020 |
2.46 Psychology Unearthed by COVID-19 Precautions & Polygenic Risk Score with Dr. Venk Murthy
|
Apr 11, 2020 |
2.45 Viral Spread of SARS-CoV-2, Rationing Resources, "Evidence Fiasco", & Classical Hematology Chat
|
Apr 01, 2020 |
2.44 ICU Management of COVID-19 with Dr. Benjamin Singer
|
Mar 25, 2020 |
2.43 BONUS! Novel Coronavirus and the COVID-19 Response in Oregon with Dr. John Townes
|
Mar 18, 2020 |
2.42 Quality-of-Life Measurement in Oncology, KnowYourTumor, & Question of the Week
|
Mar 17, 2020 |
2.41 BONUS! Clinical Trials Part 2: Crossover and Control Arms
|
Mar 11, 2020 |
2.40 BEACON part 2, NALA, & Molecular Pathology and Next-Generation Sequencing with Dr. David Carr
|
Mar 05, 2020 |
2.39 Effectiveness of Newer-Generation Antidepressants with Dr. Michael Hengartner
|
Feb 27, 2020 |
2.38 KEYNOTE-048, Academic Currency, & Trials in Low/Mid-Income Countries with Dr. Bishal Gyawali
|
Feb 19, 2020 |
2.37 Careerism, Presenting Abstracts, Twitter and the K-Index, & Classical Hematology Chat
|
Feb 14, 2020 |
2.36 Thought Leaders, NELSON, & Reliance on P Values in Cancer Trials with Dr. Sam Rubinstein
|
Feb 07, 2020 |
2.35 BONUS! How to Keep Up with the New Information in Medicine
|
Jan 31, 2020 |
2.34 Red Light, Pola for DLBCL, Hem/Onc Question of the Week, & TAILORx with Dr. Ali Khaki
|
Jan 24, 2020 |
2.33 Olaparib and POLO & the Classical Fallacies of Cancer Screening with Dr. H Gilbert Welch
|
Jan 15, 2020 |
2.32 BONUS! Clinical Trials Part 1: Thinking Better About Cancer Medicine
|
Jan 10, 2020 |
2.31 Listener Questions, Responsibility of Reviewers, & Duration of Response with Dr. Bishal Gyawali
|
Jan 07, 2020 |
2.30 Questions from a Medical Student & Epidemiology with Dr. Ellie Murray
|
Jan 03, 2020 |
2.29 Time from Diagnosis to Treatment in AML and Real-World Data with Dr. Sherrie Aspinall
|
Dec 27, 2019 |
2.28 Trastuzumab in Later Lines of Therapy for HER2+ Breast Cancer, Kaplan-Meier Curves, & Patreon
|
Dec 20, 2019 |
2.27 BONUS! Use of Bone-Modifying Agents Among Medicare Beneficiaries with MM with Dr. Arjun Gupta
|
Dec 12, 2019 |
2.26 Questions of the Week: Hematology/Oncology, USMLE Step 2 CK, & a bonus Hematology/Oncology
|
Dec 09, 2019 |
2.25 Questions of the Week: Hematology/Oncology, the USMLE Step 2 CK, & One From a Med Student
|
Dec 02, 2019 |
2.24 Questions of the Week: the USMLE Step 2 CK, Hematology/Oncology, & One From a Med Student
|
Nov 26, 2019 |
2.23 Question of the Week & Ethics and Inefficiencies of Clinical Trials with Dr. Jonathan Kimmelman
|
Nov 20, 2019 |
2.22 Question of the Week & EMR, Talking to Patients, and Being a Doctor with Dr. Robert Hirschtick
|
Nov 15, 2019 |
2.21 Aiming for the Hard Targets & Harm From Screening and Overdiagnosis with Dr. H Gilbert Welch
|
Nov 08, 2019 |
2.20 "Courageous Skeptics", Lenalidomide, QOTW, and a Political Conversation with Dr. Andy Saultz
|
Nov 01, 2019 |
2.19 Remembering Dr. Bernard Fisher & Self-Diagnosis with Dr. Mark Lewis
|
Oct 25, 2019 |
2.18 Questions of the Week, Talking About Toxicity, ASCO Guidelines Authors' COI with Dr. Eitan Amir
|
Oct 18, 2019 |
2.17 Questions of the Week, BEACON, & Use of Subacuate Rehab with Dr. Jonathan Yeh
|
Oct 08, 2019 |
2.16 FLAURA & What Truly Matters in the Career of an Academic Physician with Dr. Vinay Prasad
|
Oct 02, 2019 |
2.15 Bonus! The Value of Progression-Free Survival as a Treatment Endpoint with Dr. Michael Raphael
|
Sep 26, 2019 |
2.14 Questions of the Week & Qualifications of a Fellowship Applicant with Dr. Jeremy Cetnar
|
Sep 24, 2019 |
2.13 BONUS! RCTs Supporting Approvals of Cancer Drugs by EMA with Dr. Huseyin Naci
|
Sep 20, 2019 |
2.12 Questions of the Week, Ethics of RCTs, & Transmission and Medical Overuse with Dr. Dan Morgan
|
Sep 17, 2019 |
2.11 Questions of the Week, When RCTs are Necessary, & AYA Oncology with Dr. Adam Duvall
|
Sep 12, 2019 |
2.10 Questions of the Week: the USMLE Step 2 CK, the MKSAP, & Hematology/Oncology
|
Sep 05, 2019 |
2.09 Questions of the Week & Informed Consent in Clinical Trials with Dr. Lynn Jansen
|
Aug 28, 2019 |
2.08 Questions of the Week: the MKSAP, the USMLE Step 2 CK, & From a Med Student
|
Aug 22, 2019 |
2.07 Translational Research & Physical Examination Pet Peeves with Dr. Adam Cifu
|
Aug 16, 2019 |
2.06 Heart Failure, Choosing a Specialty, & the Bayesian Approach with Dr. Frank Harrell
|
Aug 06, 2019 |
2.05 Reup! Cancer Screening 101 with Dr. Adam Obley
|
Jul 31, 2019 |
2.04 Reup! Tumor-Treating Fields for Glioblastoma with Dr. Michael Hayes
|
Jul 30, 2019 |
2.03 Dr. Charles Moertel and the Modern Oncologist & Cancer Screening 101 with Dr. Adam Obley
|
Jul 23, 2019 |
2.02 BONUS! Improving Access to Prescription Drugs through Policy Change with Dr. Stacie Dusetzina
|
Jul 17, 2019 |
2.01 Selinexor, ECHELON-2, Parachutes, Tumor-Treating Fields, & MedTwitter
|
Jul 12, 2019 |
1.68 Voxeletor with Dr. Olson & Humanizing Cancer, Defining Cancer, and more with Dr. David Steensma
|
Jul 05, 2019 |
1.67 MONALEESA-7 and the Cost of Cancer Drugs with Dr. Stacie Dusetzina
|
Jun 27, 2019 |
1.66 Employing Medical Writers & Frequentist vs Bayesian Methods with Dr. Allen Pannell
|
Jun 20, 2019 |
1.65 BONUS! Focusing and Building Your Presence on Twitter
|
Jun 12, 2019 |
1.64 Effectiveness of Cancer Screening with Dr. Joaquín Chapa and POLO with Dr. Emerson Chen
|
Jun 06, 2019 |
1.63 POLO, TITAN, & from ASCO: FDA Approval, Surrogate Endpoints, and Patient Experience
|
Jun 04, 2019 |
1.62 Rates of Cancer Screening, BILCAP Outcry, Waterfall Plots and Response Rate, & Dr. Jeff Sharman
|
May 23, 2019 |
1.61 Postpublication Metrics of RCTs, PCP Appointment Time, Bortezomib, & Dr. Christopher Booth
|
May 15, 2019 |
1.60 I-PREDICT, Flawed Phase I Trials, & the Cost of Drugs with Dr. Daniel Hartung
|
May 09, 2019 |
1.59 BONUS! Should Evidence Come with an Expiration Date? with Palmer Greene
|
May 08, 2019 |
1.58 Magic Mouthwash with Dr. Arjun Gupta & Precision Oncology with Dr. Talal Hilal
|
May 07, 2019 |
1.57 BONUS! Control Arm Quality in RCTs Leading to Anticancer Drug FDA Approval with Dr. Talal Hilal
|
May 02, 2019 |
1.56 BONUS! Real World Data & the Search for Meaningful Cancer Care with Dr. Christopher Booth
|
May 01, 2019 |
1.55 Role of a Professional Society & More with Dr. Cliff Hudis of ASCO
|
Apr 29, 2019 |
1.54 Association of Patient Characteristics and Tumor Genomics with Clinical Outcomes & SABR-COMET
|
Apr 18, 2019 |
1.53 CALGB 50303, REMoDL-B, & REMS, Orphan Drug Act, and Role of the FDA with Dr. Ameet Sarpatwari
|
Apr 11, 2019 |
1.52 BILCAP & DOACs for Thromboprophylaxis in Patients with Cancer with Dr. Sven Olson
|
Apr 04, 2019 |
1.51 BONUS! Study Time Reduction Using Surrogate End Points with Dr. Emerson Chen
|
Apr 02, 2019 |
1.50 Replacing RCTs, Physicians on Twitter, Open-Access, & Orthopedics with Dr. Kathryn Schabel
|
Mar 29, 2019 |
1.49 Student Questions, Boeing 737 Max, Pancreatic Surveillance, Leukemia Drugs with Dr. Elihu Estey
|
Mar 22, 2019 |
1.48 Falsified Data in Meta-Analyses and the Expert Halo Effect with Dr. Stephanie Halvorson
|
Mar 13, 2019 |
1.47 BONUS! Medical Reversal: Class Lecture
|
Mar 11, 2019 |
1.46 BONUS! Personal Finances with Dr. Tom Beer
|
Mar 08, 2019 |
1.45 Real-World Data, Gottlieb, & Using the EHR for Meaningful Improvement with Dr. Deborah Cohen
|
Mar 06, 2019 |
1.44 BONUS! Screen Time and Children's Performance
|
Mar 01, 2019 |
1.43 Andexanet Alfa with Dr. Tom Deloughery & National Medicaid Policy with Dr. John McConnell
|
Feb 22, 2019 |
1.42 Caplacizumab for TTP with Dr. Sven Olson & Economics of Drug Pricing with Dr. Inma Hernández
|
Feb 13, 2019 |
1.41 Geneva Oath and Financial Relationships Among Guideline Authors with Dr. Joshua Niforatos
|
Feb 09, 2019 |
1.40 The World of Hematology with Dr. Thomas Deloughery
|
Feb 06, 2019 |
1.39 Looking Back On a Tenure in Medicine with Dr. Alex Denes
|
Feb 02, 2019 |
1.38 Lartruvo, New Directions for Cancer Trials, Gene Expression Profiling, & Dr. Miriam Knoll
|
Jan 26, 2019 |
1.37 BONUS! Medical Reversal for a General Audience
|
Jan 18, 2019 |
1.36 Generic Price Competition & Military Surgical Advances with Dr. Martin Schreiber
|
Jan 15, 2019 |
1.35 BONUS! Conflict of Interest in Oncology
|
Jan 10, 2019 |
1.34 Endpoints in ECOG-ACRIN 2511, Update to KEYNOTE-024, & Mentorship with Dr. Joseph Shatzel
|
Jan 10, 2019 |
1.33 Guarantee-Time Bias & Trials, Philanthropy, and Cancer Research with Dr. Tom Beer
|
Jan 05, 2019 |
1.32.1 Radiation Oncology with Dr. Brian Kavanagh
|
Jan 04, 2019 |
1.32 Rating Metrics, Conflict of Interest in the News, & Radiation Oncology with Dr. Brian Kavanagh
|
Jan 03, 2019 |
1.31 Ketogenic Diet, COMET-1 and COMET-2, the Health Insurance Marketplace with Dr. Jane Zhu
|
Dec 27, 2018 |
1.30 BONUS! Clinical Trial Endpoints, Drug Approval, Incentives in Oncology
|
Dec 19, 2018 |
1.29 RCT of Parachutes and Frameworks for Internal Medicine with Dr. Andre Mansoor
|
Dec 18, 2018 |
1.28 Questionable FDA Drug Approvals and Building a Career with Dr. Chadi Nabhan
|
Dec 13, 2018 |
1.27 BONUS! Medical Reversal
|
Dec 06, 2018 |
1.26 Lesson From an ASH Abstract, Behind the Scenes of a Residency Program with Dr. Sima Desai
|
Dec 04, 2018 |
1.25 Welch's Legacy, Interpreting NGS, Uncertainty over Pregabalin, Beyond EBM with Dr. Sam Edwards
|
Nov 27, 2018 |
1.24 Useless Medical Conferences and Dr. Adam Obley on Vascepa, Fish Oil, Vitamin D and Methotrexate
|
Nov 20, 2018 |
1.23 BONUS! Developing Technology with Fewer Reversals: Maybe We Need More Translation Failure
|
Nov 15, 2018 |
1.22 Elo-Pom-Dex, Immunotherapy Combos, Inherent Bias, and the FDA with Dr. Erick Turner
|
Nov 13, 2018 |
1.21 Nab-Paclitaxel in CCA, OS of PALOMA-3, Transparency, and Dr. Talal Hilal's Advice for Trainees
|
Nov 06, 2018 |
1.20 Precision Oncology: Some Benefit, Mostly Hype and Mentorship with Dr. Andrae Vandross
|
Oct 30, 2018 |
1.19 BONUS! Introduction to Cancer Drug Policy
|
Oct 26, 2018 |
1.18 IMpassion130 and Hot-Spotting with Dr. Brian Chan
|
Oct 23, 2018 |
1.17 BONUS! Interpretation of Cancer Clinical Trials
|
Oct 22, 2018 |
1.16 BONUS! Crowdsourcing Data Analysis and Medical Reversal: Why 40% of What We Do is Wrong
|
Oct 17, 2018 |
1.15 Minimally Effective Treatments, CheckMate 331, and Dr. Adam Obley on Low-Value Healthcare
|
Oct 16, 2018 |
1.14 BONUS! Immunotherapy in Desperation and the Pennington Lecture: Myths of Medicine and Marketing
|
Oct 12, 2018 |
1.13 KEYNOTE-189, Dr. Talal Hilal on MRD, and Medical Education with Dr. Adam Cifu
|
Oct 08, 2018 |
1.12 BONUS! Evidence-Based Medicine Has Been Hijacked in Oncology
|
Oct 03, 2018 |
1.11 Peanut Gallery, Research Parasites, Appendectomies, HRQoL and PFS, Dr. Bishal Gyawali
|
Oct 02, 2018 |
1.10 Criticism via Twitter, PACIFIC, PCI for CAD, and Dr. Rebecca Cooney of The Lancet
|
Sep 25, 2018 |
1.09 Response Rate in Phase I trials, JACOB, and MI, Stroke, and Metastasis as Hard Endpoints
|
Sep 20, 2018 |
1.08 Hyperprolific authors, NCCN with Jeff Wagner, and Dr. Renee Dversdal on Ultrasounds
|
Sep 14, 2018 |
1.07 Adjuvant Sunitinib in RCC, future of EBM with Dr. John Mandrola
|
Sep 11, 2018 |
1.06 RELEVANCE, Jenny Gill, and Dr. Catherine Livingston of the Oregon Health Authority
|
Sep 07, 2018 |
1.05 Cost and Efficacy of Cancer Drugs, ECHELON-1, Dr. Derrick Tao, and EBM with Dr. Martha Gerrity
|
Sep 05, 2018 |
1.04: Nutritional Epi, Lenvatinib, Nivo and Ipi for Melanoma, and Dr. Avi O'Glasser
|
Aug 30, 2018 |
1.03: RWE, Right to Try, Talazoparib, Nivolumab, and Dr. Andrae Vandross
|
Aug 21, 2018 |
1.02: HemOnc Fellowship and Hype in Cancer Medicine with Dr. Jeremy Cetnar
|
Aug 16, 2018 |
1.01: Introduction and Dr. Adam Obley
|
Aug 14, 2018 |